{"id":28821,"date":"2016-08-11T02:36:48","date_gmt":"2016-08-11T09:36:48","guid":{"rendered":"http:\/\/lifeboat.com\/blog\/2016\/08\/biologics-on-demand-darpa-and-mit-look-to-manufacture-on-the-battlefield"},"modified":"2017-06-04T14:26:17","modified_gmt":"2017-06-04T21:26:17","slug":"biologics-on-demand-darpa-and-mit-look-to-manufacture-on-the-battlefield","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2016\/08\/biologics-on-demand-darpa-and-mit-look-to-manufacture-on-the-battlefield","title":{"rendered":"Biologics on-demand: DARPA and MIT look to manufacture on the battlefield"},"content":{"rendered":"<p style=\"padding-right: 20px\"><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/biologics-on-demand-darpa-and-mit-look-to-manufacture-on-the-battlefield.jpg\"><\/a><\/p>\n<p>The US Department of Defense has developed a portable, on-demand biopharmaceutical production system that could be used in warzones to make treatments at point-of-care.<\/p>\n<p>The platform was developed as part of a US Defense Advanced Research Projects Agency (DARPA) program to provide far-forward-deployed Service members <i>\u201cwhat they need when they need it, obviating the need for individual drug stockpiling, cold storage, and complex logistics,\u201d<\/i> Tyler McQuade, program manager for DARPA\u2019s Battlefield Medicine program, told <a href=\"http:\/\/Biopharma-Reporter.com\">Biopharma-Reporter.com<\/a>.<\/p>\n<p>The platform, developed in conjunction with researchers at the Massachusetts Institute of Technology (MIT), consists of a biologics expression system engineered to secrete multiple therapeutic proteins and a millilitre-scale perfusion microfluidic platform.<\/p>\n<p><!-- Link: <a href=\"http:\/\/www.biopharma-reporter.com\/Upstream-Processing\/Biopharma-on-demand-biologics-on-the-battlefield-with-DARPA-tech\">http:\/\/www.biopharma-reporter.com\/Upstream-Processing\/Biopha...DARPA-tech<\/a> --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The US Department of Defense has developed a portable, on-demand biopharmaceutical production system that could be used in warzones to make treatments at point-of-care. The platform was developed as part of a US Defense Advanced Research Projects Agency (DARPA) program to provide far-forward-deployed Service members \u201cwhat they need when they need it, obviating the need [\u2026]<\/p>\n","protected":false},"author":409,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-28821","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/28821","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/409"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=28821"}],"version-history":[{"count":3,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/28821\/revisions"}],"predecessor-version":[{"id":66624,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/28821\/revisions\/66624"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=28821"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=28821"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=28821"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}